Emvizid 0.2 Tablet SR
Marketer
Zanjoe Formulation Private Limited
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Emvizid 0.2 Tablet SR
Diabexe 0.2mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Diabexe 0.2mg Extended-Release tablets should be taken with meals, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, vomiting, diarrhea, abdominal pain, headache, edema, blurred vision, and fractures. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring, along with blood cell and liver function tests, may be recommended by your doctor.
Primary Ingredients of Emvizid 0.2 Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Emvizid 0.2 Tablet SR
Managing type 2 diabetes
Major Benefits of Emvizid 0.2 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Emvizid 0.2 Tablet SR with a meal.
Common Side effects of Emvizid 0.2 Tablet SR:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Emvizid 0.2 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Emvizid 0.2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Emvizid 0.2 Tablet SR works:
Emvizid SR 0.2mg tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Emvizid 0.2 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Emvizid 0.2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCAUTION
The extended-release Emvizid 0.2mg tablet requires careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Emvizid 0.2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Emvizid 0.2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Emvizid 0.2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Emvizid 0.2 Tablet SR typically begins at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Emvizid 0.2 Tablet SR :
NA
Facts to Know About Emvizid 0.2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently